血栓管理設備市場規模、佔有率和成長分析：按產品類型、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球血栓管理設備市場價值為 19 億美元，預計到 2025 年將成長至 20.2 億美元，到 2033 年將成長至 32.6 億美元，預測期（2026-2033 年）複合年成長率為 6.2%。

全球血栓管理設備市場的主要驅動力是快速診斷和清除血栓的需求不斷成長，而人口老化以及心血管和腦血管疾病盛行率的上升則進一步推動了這一需求。該市場涵蓋了多種對降低患者發病率、長期殘疾率和醫療成本至關重要的產品類別，包括照護現場凝血監測儀、導管導引溶栓系統和機械血栓切除工具。隨著醫院致力於提高營運效率和改善患者預後，臨床證據、醫療改革和技術進步的融合正在加速市場成長。此外，人工智慧在血栓檢測中的應用，透過自動化影像分析和加速治療流程，最佳化了工作流程，使先進的血栓管理工具對醫療專業人員更具吸引力。

全球血栓管理設備市場的成長要素

心血管疾病發病率的上升顯著推動了血栓管理設備的需求，因為這擴大了需要診斷和治療的患者群體。隨著血栓性疾病患者數量的增加，醫療機構正日益重視急性治療和預防措施，以有效控制血栓的形成和溶解。這種持續的臨床需求促使製造商透過改進設計、提供全面的培訓和製定有效的分銷策略來提升設備的供應能力。因此，醫院對血栓管理設備的應用率不斷提高，並透過更廣泛的臨床應用推動了整體市場的成長，反映了醫療保健領域動態且快速發展的現狀。

全球血栓管理設備市場的限制因素

全球血栓管理設備市場面臨許多限制因素，主要原因在於這些設備及相關手術的高成本。這種經濟負擔限制了病患的使用，尤其是在醫療資源匱乏的機構，導致採購評估更加嚴格。因此，醫院和診所可能會推遲採用這些技術，或僅將其用於最嚴重的病例，從而降低了常規使用率，阻礙了市場滲透。此外，資金壓力也可能限制對新技術所需的培訓和基礎設施的投資，最終阻礙技術的廣泛應用，並將基本客群限制在資金雄厚的機構。

全球血栓管理設備市場趨勢

全球血栓管理器械市場正經歷著微創介入治療的顯著轉變，強調縮短恢復時間和降低手術風險。這一趨勢的驅動力來自器械設計的創新，例如小型化和先進的輸送機制，這些創新正在加速其在包括門診中心和介入治療團隊在內的各種醫療機構中的應用。隨著醫療服務提供者和保險公司將改善病患體驗和高效的診療路徑放在首位，對支援門診管理的器械的投資也在增加。這種發展將促進跨學科協作工作流程，催生新的服務模式，增強市場競爭優勢，並最終重塑血栓管理的整體情況。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球血栓管理設備市場規模：依產品類型分類

• 機械血栓除去裝置
  • 抽吸式血栓除去裝置
  • 血栓摘取支架
  • 再入血栓除去裝置
  • 超音波輔助血栓除去裝置
  • 旋轉血栓除去裝置
  • 其他
• 神經血管血栓除去裝置裝置
  • 線圈取出器
  • 血栓切除導管
  • 血流恢復裝置
• 下腔靜脈（IVC）濾器
  • 永久性下腔靜脈濾器
  • 可回收下腔靜脈（IVC）濾器
• 用於治療慢性完全閉塞（CTO）的裝置

全球血栓管理設備市場規模：按應用領域分類

• 缺血性中風
• 深層靜脈栓塞症（DVT）
• 肺動脈栓塞（PE）
• 周邊動脈疾病（PAD）
• 冠狀動脈疾病
• 其他

全球血栓管理設備市場規模：依最終用戶分類

• 醫院
• 門診手術中心（ASC）
• 專科診所
• 心臟導管檢查室
• 神經血管中心

全球血栓管理設備市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Boston Scientific Corporation
• Medtronic plc
• Penumbra, Inc.
• Stryker Corporation
• Terumo Corporation
• Johnson & Johnson MedTech
• Teleflex Incorporated
• Becton, Dickinson and Company
• Abbott Laboratories
• Koninklijke Philips NV
• Merit Medical Systems, Inc.
• Argon Medical Devices, Inc.
• AngioDynamics, Inc.
• Inari Medical, Inc.
• Acandis GmbH
• MicroVention, Inc.
• Asahi Intecc Co., Ltd.
• Cook Medical
• Imperative Care, Inc.
• Surmodics, Inc.

結論與建議

Global Clot Management Devices Market size was valued at USD 1.9 Billion in 2024 and is poised to grow from USD 2.02 Billion in 2025 to USD 3.26 Billion by 2033, growing at a CAGR of 6.2% during the forecast period (2026-2033).

The global clot management devices market is significantly influenced by the increasing demand for rapid diagnosis and removal of thrombi, fueled by an aging populace and the rising prevalence of cardiovascular and cerebrovascular diseases. This market includes various categories such as point-of-care coagulation monitors, catheter-directed thrombolysis systems, and mechanical thrombectomy tools, all essential for reducing patient morbidity, long-term disabilities, and healthcare expenses. The convergence of clinical evidence, reimbursement reforms, and technological advancements serves as a catalyst for market growth, as hospitals seek to enhance their operational efficiency and improve patient outcomes. Additionally, the integration of AI in thrombus detection is optimizing workflow by automating image analysis and expediting treatment processes, making advanced clot management tools more appealing to healthcare providers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clot Management Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clot Management Devices Market Segments Analysis

Global clot management devices market is segmented by product type, application, end user and region. Based on product type, the market is segmented into Mechanical Thrombectomy Devices, Neurovascular Clot Retrieval Devices, Inferior Vena Cava (IVC) Filters and Chronic Total Occlusion (CTO) Devices. Based on application, the market is segmented into Ischemic Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Peripheral Arterial Disease (PAD), Coronary Artery Disease and Others. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Cardiac Catheterization Laboratories and Neurovascular Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Clot Management Devices Market

The growing incidence of cardiovascular diseases significantly boosts the demand for clot management devices, as it broadens the patient population needing diagnosis and treatment. With an increasing number of patients suffering from thrombotic conditions, healthcare providers are increasingly utilizing both acute and preventive measures to effectively manage clot formation and resolution. This ongoing clinical necessity motivates manufacturers to enhance their device offerings, focusing on improved designs, comprehensive training, and effective distribution strategies. Consequently, this fosters a higher rate of adoption in hospital environments and promotes overall market growth through expanded clinical applications, reflecting a dynamic and responsive healthcare landscape.

Restraints in the Global Clot Management Devices Market

The Global Clot Management Devices market faces significant constraints primarily due to the high costs linked to these devices and their associated procedures. This financial burden limits accessibility, particularly in healthcare settings with limited resources, leading to more stringent procurement evaluations. As a result, hospitals and clinics may postpone the adoption of these technologies or confine their use to only the most critical cases, which diminishes routine usage and hampers market penetration. Furthermore, financial pressures can limit investment in necessary training and infrastructure for newer technologies, which ultimately discourages widespread implementation and narrows the customer base to well-funded institutions.

Market Trends of the Global Clot Management Devices Market

The Global Clot Management Devices market is experiencing a significant shift towards minimally invasive interventions, emphasizing reduced recovery times and lower procedural risks. This trend is propelled by innovations in device design, including smaller profiles and advanced delivery mechanisms, which facilitate broader adoption in various care settings such as ambulatory centers and interventional teams. As providers and payers prioritize improved patient experiences and efficient care pathways, there is a growing investment in devices that support outpatient management. This evolution fosters collaborative workflows across specialties, enabling new service models and enhancing competitive differentiation within the market, ultimately reshaping the landscape of clot management.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Clot Management Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Mechanical Thrombectomy Devices
  • Aspiration Thrombectomy Devices
  • Stent Retrievers
  • Rheolytic Thrombectomy Devices
  • Ultrasound-Assisted Thrombectomy Devices
  • Rotational Thrombectomy Devices
  • Others
• Neurovascular Clot Retrieval Devices
  • Coil Retrievers
  • Clot Extraction Catheters
  • Flow Restoration Devices
• Inferior Vena Cava (IVC) Filters
  • Permanent IVC Filters
  • Retrievable IVC Filters
• Chronic Total Occlusion (CTO) Devices

Global Clot Management Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Ischemic Stroke
• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism (PE)
• Peripheral Arterial Disease (PAD)
• Coronary Artery Disease
• Others

Global Clot Management Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Cardiac Catheterization Laboratories
• Neurovascular Centers

Global Clot Management Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson MedTech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Argon Medical Devices, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inari Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroVention, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Imperative Care, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Surmodics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations